Recalls / Active ingredient / Mometasone Furoate Monohydrate
Mometasone Furoate Monohydrate
1 FDA drug recall involving the active ingredient “Mometasone Furoate Monohydrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-09-24 | Class II | Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metere | Glenmark Pharmaceuticals Inc., USA |